Clinical trial
OMNI Study--Assessing Therapies in Medtronic Pacemaker, Defibrillator, and…
NCT00277524 · Medtronic Cardiac Rhythm and Heart Failure, Industry · Terminated
Key facts
| NCT number | NCT00277524 |
|---|---|
| Title | OMNI Study--Assessing Therapies in Medtronic Pacemaker, Defibrillator, and Cardiac Resynchronization Therapy Devices. |
| Official title | OMNI Study--Assessing Therapies in Medtronic Pacemaker, Defibrillator, and Cardiac Resynchronization Therapy Devices. |
| Acronym | OMNI |
| Lead sponsor | Medtronic Cardiac Rhythm and Heart Failure, Industry |
| Collaborators | Medtronic Industry |
| Status | Terminated |
| Study type | Observational |
| Conditions | Tachycardia, Ventricular, Heart Failure, Congestive, Ventricular Fibrillation, Ventricular Dysfunction, Bradycardia |
| Enrollment | 3,032 |
| Start date | Aug 1, 2005 |
| Primary completion | Nov 1, 2010 |
| Completion | Nov 1, 2010 |
| First posted | Jan 16, 2006 |
| Last update posted | Aug 28, 2013 |
| Countries | United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: